114 related articles for article (PubMed ID: 32683690)
1. Trends in hysterectomy-corrected uterine cancer mortality rates during 2002 to 2015: mortality of nonendometrioid cancer on the rise?
Gustafson LW; Booth BB; Kahlert J; Ørtoft G; Mejlgaard E; Clarke MA; Wentzensen N; Rositch AF; Hammer A
Int J Cancer; 2021 Feb; 148(3):584-592. PubMed ID: 32683690
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype.
Clarke MA; Devesa SS; Hammer A; Wentzensen N
JAMA Oncol; 2022 Jun; 8(6):895-903. PubMed ID: 35511145
[TBL] [Abstract][Full Text] [Related]
3. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
Clarke MA; Devesa SS; Harvey SV; Wentzensen N
J Clin Oncol; 2019 Aug; 37(22):1895-1908. PubMed ID: 31116674
[TBL] [Abstract][Full Text] [Related]
4. Hysterectomy-corrected cervical cancer mortality rates in Denmark during 2002-2015: A registry-based cohort study.
Hammer A; Kahlert J; Gravitt PE; Rositch AF
Acta Obstet Gynecol Scand; 2019 Aug; 98(8):1063-1069. PubMed ID: 30868579
[TBL] [Abstract][Full Text] [Related]
5. The temporal and age-dependent patterns of hysterectomy-corrected cervical cancer incidence rates in Denmark: a population-based cohort study.
Hammer A; Kahlert J; Rositch A; Pedersen L; Gravitt P; Blaakaer J; Soegaard M
Acta Obstet Gynecol Scand; 2017 Feb; 96(2):150-157. PubMed ID: 27861705
[TBL] [Abstract][Full Text] [Related]
6. Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers.
Nieto VL; Huang Y; Hou JY; Tergas AI; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2018 Nov; 219(5):463.e1-463.e12. PubMed ID: 30086293
[TBL] [Abstract][Full Text] [Related]
7. Declining hysterectomy prevalence and the estimated impact on uterine cancer incidence in Scotland.
Ruiz de Azua Unzurrunzaga G; Brewster DH; Wild SH; Sivalingam VN
Cancer Epidemiol; 2019 Apr; 59():227-231. PubMed ID: 30836220
[TBL] [Abstract][Full Text] [Related]
8. State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008.
Siegel RL; Devesa SS; Cokkinides V; Ma J; Jemal A
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):25-31. PubMed ID: 23125334
[TBL] [Abstract][Full Text] [Related]
9. Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers.
Tai YJ; Chiang CJ; Chiang YC; Wu CY; Lee WC; Cheng WF
Sci Rep; 2023 Jan; 13(1):1019. PubMed ID: 36658172
[TBL] [Abstract][Full Text] [Related]
10. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
Beavis AL; Gravitt PE; Rositch AF
Cancer; 2017 May; 123(6):1044-1050. PubMed ID: 28112816
[TBL] [Abstract][Full Text] [Related]
11. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage.
Madison T; Schottenfeld D; Baker V
Cancer; 1998 Oct; 83(8):1546-54. PubMed ID: 9781948
[TBL] [Abstract][Full Text] [Related]
12. Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.
Ør Knudsen A; Schledermann D; Nyvang GB; Mogensen O; Herrstedt J;
Acta Oncol; 2016; 55 Suppl 1():65-73. PubMed ID: 26784001
[TBL] [Abstract][Full Text] [Related]
13. Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe.
Bray F; Loos AH; Oostindier M; Weiderpass E
Int J Cancer; 2005 Oct; 117(1):123-31. PubMed ID: 15880435
[TBL] [Abstract][Full Text] [Related]
14. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994.
Cornelison TL; Trimble EL; Kosary CL
Gynecol Oncol; 1999 Sep; 74(3):350-5. PubMed ID: 10479492
[TBL] [Abstract][Full Text] [Related]
15. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
[TBL] [Abstract][Full Text] [Related]
16. Time trends in the incidence of hysterectomy-corrected overall, type 1 and type 2 endometrial cancer in Denmark 1978-2014.
Faber MT; Frederiksen K; Jensen A; Aarslev PB; Kjaer SK
Gynecol Oncol; 2017 Aug; 146(2):359-367. PubMed ID: 28545689
[TBL] [Abstract][Full Text] [Related]
17. Hysterectomy in Denmark. An analysis of postoperative hospitalisation, morbidity and readmission.
Møller C; Kehlet H; Utzon J; Ottesen B
Dan Med Bull; 2002 Nov; 49(4):353-7. PubMed ID: 12553170
[TBL] [Abstract][Full Text] [Related]
18. Trends in Hysterectomy Incidence Rates During 2000-2015 in Denmark: Shifting from Abdominal to Minimally Invasive Surgical Procedures.
Lycke KD; Kahlert J; Damgaard R; Mogensen O; Hammer A
Clin Epidemiol; 2021; 13():407-416. PubMed ID: 34103999
[TBL] [Abstract][Full Text] [Related]
19. Trends in the incidence of cancer of the corpus uteri in Denmark, 1943-1980.
Ewertz M; Jensen OM
Am J Epidemiol; 1984 May; 119(5):725-32. PubMed ID: 6720670
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
